Press Releases & News

For press inquiries, please contact press@inato.com

Inato

Inato Announces Formation of Innovation Board to Drive Clinical Research Advancements with Sites and Sponsors

Inato announces the formation of the Inato Innovation Board, bringing together senior leaders from top pharmaceutical companies and research sites to foster collaboration and drive industry advancements.

July 2024
Fast Company Logo

How this biotech company connects drugmakers with diverse clinical trial participants

Inato is named one of Fast Company's most Innovative Companies of 2024.

March 2024

Fierce Healthcare

Fierce Healthcare's Fierce 15 of 2024

Inato earns a spot on Fierce Healthcare's Fierce 15 for its role in revolutionizing partnerships between research sites and pharma, broadening patient access.

February 2024

Fierce Healthcare

What CVS' exit from clinical trials means for other retail players

Inato's Liz Beatty shares her thoughts on CVS' recent exit from clinical research and the implications for other retailers entering the space.

June 2023
Insider

See the 16-slide presentation a start up used to sell investors on a new approach to solving a $50 billion problem for Big Pharma

Inato provided Insider with the pitch deck it used to raise $20 million in Series A-2 funding.

April 2023
Medcity News

Inato Snags $20M to Make Clinical Trials More Diverse & Accessible

Inato recently raised $20 million in Series A2 funding for its two-way tech platform which brings clinical trial exposure to community-based providers.

April 2023
Fast Company

A new batch of startups aims to bring more diversity to clinical trials

After a recent FDA rule required drug makers to open up trials to underrepresented populations, startups like Inato are working to close the gap.

March 2023
Endpoints News

Big Pharma-partnered clinical trial matchmaker secures $20M to improve platform

Inato CEO Kourosh Davarpanah told Endpoints News that with the $20 million in hand, it will pursue improvements to its diversity offerings, its focus on oncology and data collection.

March 2023
Fierce Biotech

French clinical trial company Inato scores $20M funding to expand international growth

French clinical trial company Inato plans to use money from its latest fundraising round of $20 million to expand its global reach, develop new innovations and attract top talent.

March 2023
Inato

Inato Raises $20 Million in New Funding to Make Clinical Trials More Inclusive

Inato, the leading technology platform enabling access to inclusive clinical trials, today announced the close of $20 million in Series A2 funding from existing and new investors.

March 2023
Pharma Phorum

Plotting the way forward on clinical trial diversity

Liz Beatty, alongside other industry leaders, breaks down the collaboration and trust required between pharma sponsors, research sites large and small, tech solutions, and patients to make representative trials the status quo.

March 2023
Clinical Trials

To diversify clinical trials, biopharma companies look to widen the pool of investigators

A look at the ramifications of undiversified clinical trials and ways that pharma can increase representation, featuring Inato's Liz Beatty.

February 2023
Forbes

Crescendo Health’s Funding Signals Growing Momentum For The Role Platforms Can Play In Clinical Trials Innovation

While the healthcare industry has seen massive transformation since the onset of the pandemic, clinical trial operations, perhaps more quietly, has been a hotbed of business activity with fast-growing digital health companies like Inato.

January 2023
Pharma Voice

The 2023 PharmaVoice Year in Preview

Industry leaders, including Inato's Liz Beatty, describe how they are navigating the key issues of 2023 with a focus on what the industry needs to do to meet the high bar of patient expectations, and what companies can do to adopt a more consumer-centric approach to patient care and engagement.

December 2022
Pharma News Intelligence

Improving Clinical Trial Diversity Through Community and Pharmaceutical Relationships

PharmaNewsIntelligence interviewed Kourosh Davarpanah, CEO and Co-founder of Inato, and Teresa L. Tocher, Director of Clinical Research at Clinical Trials Management Services, LLC, who provided some insight into the current, traditional clinical trial landscape and how clinical trial sites are connected with pharmaceutical companies to offer their patients access to care.

November 2022
Clinical Trials Arena

Inato improves platform to boost trial access and inclusion

By leveraging the Inato platform, research sites can reuse data from one trial to another.

November 2022
Inato

Inato Drives Improvements to Access and Inclusion in Global Clinical Trials with Latest Platform Enhancements

Today, Inato announced its latest platform enhancements. The company also grew global community site adoption of the Inato platform by more than 120% year-over-year (YOY).

November 2022
Fierce Healthcare

Startup Inato built technology to reach the 90% of sites ignored in clinical research. Here's how it works

Inato CEO Kourosh Davarpanah shared the company's growth over 2022 and explains how their platform empowers community-based investigators to bring the right trials to their patients.

November 2022
Inato

Inato to Host Roundtables on Improving Clinical Trials Through New Approaches to Site Selection

Inato hosts two discussions around challenges in accessing patients and innovative approaches to overcoming those barriers and partnering with community-based sites at the Clinical Operations Strategy Meeting on May 18 in Cambridge, Massachusetts

May 2022
Authority Magazine

Health Tech: Kourosh Davarpanah On How Inato’s Technology Can Make An Important Impact On Our Overall Wellness

In an interview with Authority Magazine for their series on "Technology Making An Important Positive Social Impact" Inato CEO, Kourosh Davarpanah, shares the motivation behind starting Inato and the positive impact our technology can have on society.

May 2022
Histalk

Clinical Trials and the Data Diversity Problem

Inato CSO, Liz Beatty, describes the detrimental effect of underrepresenting minority communities in clinical trials.

May 2022
Kevin MD

A path toward clinical trial diversity

CSO, Liz Beatty, describes how the lack of diversity across clinical trials harms trial efficacy, data, and costs in op-ed.

May 2022
CBJ

California Business Journal Exclusive: The Lack Of Diversity In Clinical Trials Is Staggering

The lack of diversity in clinical trials is staggering. Liz Beatty, who has spent nearly two decades as Director of Clinical Trials at Bristol-Myers Squibb, is changing that as Inato’s Chief Strategic Officer.

March 2022
Inato

Inato appoints CSO Liz Beatty to Board of Directors

Beatty brings decades of experience in leadership and clinical trial management

March 2022
Outsourcing Pharma

Diverse site staff better fits inclusive patient population: Inato

Liz Beatty from Inato discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.

March 2022
Inato

Clinical Trial Marketplace Inato Sees Record Growth in 2021

Inato broadens clinical trial access by offering pharmaceutical companies direct access to community-based research sites and the patients they serve

February 2022
Proventa

Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato

Driven by COVID’s disparate effect on certain ethnicities, the pandemic exacerbated the issue of certain patient populations being unable to access suitable trials. Proventa spoke to Liz Beatty, Chief Strategy Officer at Inato, about how they believe this issue can be rectified.

August 2021
Carousel

Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Research More Inclusive and Efficient

The Inato Marketplace is Reinventing the Collaboration Model Between Clinical Trial Sponsors and Sites

January 2021
ACT

Clinical Trial Diversity: It’s Time to Stop Talking the Talk and Start Walking the Walk

"The lack of diversity in clinical trials is a disturbing, ethical problem that’s persisted for decades," said Liz Beatty in an article this week on Applied Clinical Trials Magazine where she discusses that it is time to stop talking the talk and start walking the walk when it comes to clinical trial diversity.

January 2021
CRN

Trendspotting: Decentralized Trials, AI, Real-World Data in 2021

Clinical Research News published an article last week on some of the top trends to watch out for in clinical trials in 2021.

January 2021
Outsourcing Pharma

Looking back, thinking ahead: industry leaders talk trends

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

December 2020
ACRP

The Future of Clinical Trials will Require a Focus on the Long Tail

Inato CEO, Kourosh Davarpanah, discusses the clinical trial landscape and why the future of clinical trials will require a focus on the long tail.

December 2020
Carousel

Inato Shares Key Company Milestones

Inato Announces the Participation of Over 300 Clinical Trial Research Sites in its Global Marketplace

September 2020
Outsourcing Pharma

Inato: insightful data can boost clinical trial diversity

A leader from the clinical research technology firm talks about the importance of a diverse patient population and ways to hit the target.

August 2020
Xconomy

Clinical Trial Diversity Isn’t Just a Moral Issue–It’s a Scientific Imperative

Inato's Liz Beatty pens an op-ed in Xconomy on the pressing need for clinical trial diversity.

July 2020
ACT

How Clinical Trial Research Sites Can Gain Access to a More Level Playing Field

To overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.

July 2020
SCRS

SCRS Welcomes Inato to the Global Impact Partner Program

Inato Joins SCRS as a Global Impact Partner

June 2020
CRN

Why the Clinical Trial Industry Needs Dynamic and Inclusive Marketplaces

By connecting supply with demand and eventually facilitating a financial transaction, marketplaces provide an online platform for supply and demand to efficiently find one another and transact seamlessly.

March 2020
Fierce Biotech

Inato raises $14M to unlock trial site potential

Inato raises $14 million series A round to “unlock the potential of the many unengaged research sites.”

February 2020
Montage

Inato Raises $14M Series A

Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures

February 2020
Endpoints News

The Sanofi-partnered startup finding clinical trials for the 90%

Inato announced a $14 million Series A round led by Obvious Ventures and Cathay Innovation, and joined by Serena and Fly Ventures.

February 2020
Liz Beatty

Appointment: Liz Beatty CSO

Inato Appoints Pharmaceutical Industry Veteran Liz Beatty as Chief Strategy Officer

April 2019